LEISHMANIA RESISTANT TO SODIUM STIBOGLUCONATE - DRUG-ASSOCIATED MACROPHAGE-DEPENDENT KILLING

被引:37
作者
IBRAHIM, ME
HAGALI, M
ELHASSAN, AM
THEANDER, TG
KHARAZMI, A
机构
[1] SUDAN MED RES COUNCIL,KHARTOUM,SUDAN
[2] UNIV KHARTOUM,FAC MED,DEPT PATHOL,KHARTOUM,SUDAN
[3] RIGSHOSP,DEPT CLIN MICROBIOL,DK-2100 COPENHAGEN,DENMARK
来源
PARASITOLOGY RESEARCH | 1994年 / 80卷 / 07期
关键词
D O I
10.1007/BF00933004
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
A total of 17 Leishmania isolates, 6 of them isolated from antimony-resistant patients, were collected in the Sudan and tested for their sensitivity to sodium stibo,oluconate (Pentostam) as promastigotes. Six of those isolates were tested as amastigotes infecting a murine macrophage cell line. The results indicated that the conventional promastigote screening assay did not correlate with the clinical picture, whereas the amastigote/macrophage system produced results that pertained to the in vivo responses to the drug. A laboratory-generated resistant strain of L. major was adapted to grow at a high concentration of Pentostam (1000 mu g/ml) as promastigotes but was quite sensitive to the drug at much lower concentrations in the amastigote/(macrophage system (20 mu g/ml), thus suggesting that Pentostam's inhibitory action is mediated through the macrophage rather than through a direct toxic effect exerted on the parasite.
引用
收藏
页码:569 / 574
页数:6
相关论文
共 31 条
[1]  
ARORA SK, 1991, MED MICROBIOL IMMUN, V180, P21, DOI 10.1007/BF00191697
[2]   EPIDEMIC VISCERAL LEISHMANIASIS IN SOUTHERN SUDAN - IDENTITY AND SYSTEMATIC POSITION OF THE PARATIES FROM PATIENTS AND VECTORS [J].
ASHFORD, RW ;
SEAMAN, J ;
SCHORSCHER, J ;
PRATLONG, F .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1992, 86 (04) :379-380
[3]  
BADARO R, 1993, NEW ENGL J MED, V167, P13
[4]   AN INVITRO MODEL FOR INVESTIGATION OF CHEMOTHERAPEUTIC-AGENTS IN LEISHMANIASIS [J].
BERMAN, JD ;
WYLER, DJ .
JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (01) :83-86
[5]   VISCERAL LEISHMANIASIS UNRESPONSIVE TO ANTIMONIAL DRUGS .1. CLINICAL AND IMMUNOLOGICAL STUDIES [J].
BRYCESON, ADM ;
CHULAY, JD ;
HO, M ;
MUGAMBII, M ;
WERE, JB ;
MUIGAI, R ;
CHUNGE, C ;
GACHIHI, G ;
MEME, J ;
ANABWANI, G ;
BHATT, SM .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1985, 79 (05) :700-704
[6]  
CROFT S L, 1986, Parasitology Today, V2, P64, DOI 10.1016/0169-4758(86)90157-2
[7]  
DEBEER P, 1990, LANCET, V335, P224, DOI 10.1016/0140-6736(90)90313-T
[8]   POST KALA-AZAR DERMAL LEISHMANIASIS IN THE SUDAN - CLINICAL-FEATURES, PATHOLOGY AND TREATMENT [J].
ELHASSAN, AM ;
GHALIB, HW ;
ZIJLSTRA, EE ;
ELTOUM, IA ;
SATTI, M ;
ALI, MS ;
ALI, HMA .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1992, 86 (03) :245-248
[9]   LEISHMANIA-MAJOR - ANTILEISHMANIAL ACTIVITY OF METHYLBENZETHONIUM CHLORIDE [J].
ELON, J ;
MESSER, G .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1986, 35 (06) :1110-1116
[10]  
ELON J, 1991, ANN TROP MED PARASIT, V5, P323